Rocket Lab Corporation (RKLB)
Rocket Lab: Neutron Is Becoming A Real Growth Driver
I'm reiterating Rocket Lab Corporation as a Buy with a raised price target of $209 per share. Q2 2026 results delivered a record $234.1 million in revenue (62% y/y growth) and exceeded consensus expectations. RKLB achieved a record backlog, now exceeding 90 launches, and secured over $437 million in new launch contracts.
Can HASTE Help Rocket Lab Tap Into the Growing Hypersonic Market?
RKLB expands its launch portfolio through HASTE, supporting hypersonic testing and broadening opportunities in defense missions.
How Much Upside is Left in Rocket Lab Corporation (RKLB)? Wall Street Analysts Think 42.62%
The consensus price target hints at a 42.6% upside potential for Rocket Lab Corporation (RKLB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Rocket Lab: The Turnaround Is Real, Shaking Off The Neutron Delay Worries
Rocket Lab (RKLB) stays as a Speculative Buy as robust backlog growth and resilient price action offset concerns over Neutron launch delays. The bottom is clearly in. RKLB's growing backlog helps calm fears, with over 90 launches booked and strong momentum in both launch and space systems segments. Despite a forward revenue multiple above 40x and free cash flow not expected until FY 2028, I see validation in growing customer contracts and segment profitability.
Analysts raise Rocket Lab stock targets after earnings: Why it could still hit $50
Rocket Lab stock rose to the important resistance level of $80 after the company reported strong financial results. RKLB has jumped by 37% from its lowest point this year, and analysts believe that it has more upside to go as it solidifies its role in the space industry.
Rocket Lab: Neutron's First Flight And More Set Up A Profitability Inflection
Rocket Lab Corporation is nearing a major inflection point, targeting profitability in eFY27, driven by Neutron launches and the pending Iridium acquisition. RKLB's backlog has grown to $2.36b with robust defense and commercial contracts, supporting durable revenue growth and an improving operational outlook. RKLB's strong cash position and expanding contract pipeline and its pending acquisition of Iridium position it for self-financing operations and reduced reliance on equity markets in the coming years.
Rocket Lab: 36x Forward P/S Looks Like A Valuation Trap
Rocket Lab Corporation delivered 62% year-over-year revenue growth in Q2 and signed new contracts in the second quarter that added to its revenue backlog. Despite strong results, RKLB shares remain expensive based on forward revenue projections, with significant growth already priced in. RKLB shares fell 7% post-earnings (in the after-hours market), reflecting market concerns about valuation and EBITDA guidance.
Rocket Lab: The Inflection Point Is Here
Rocket Lab Corporation delivered 60% Q2 revenue growth, beat guidance, and secured over $1 billion in new contracts, yet shares fell on margin and cash burn concerns. RKLB's margin compression is driven by a shift toward lower-margin, higher-certainty government contracts, with management guiding for beneficial margin remixing beyond Q3. The $8 billion Iridium acquisition provides profitable, recurring revenue and strategic vertical integration, positioning RKLB to leverage its launch capabilities for future applications.
Rocket Lab's $2.36 Billion Backlog Says the Neutron Delay Doesn't Matter — Here's Why
The space economy has a timing problem.
RKLB Q2 Earnings Call Highlights Neutron Scale, Iridium Strategy
Rocket Lab targets record Q3 revenues as Neutron scaling, launch demand and the planned Iridium deal broaden its launch, spacecraft and applications push.
Rocket Lab reports record Q2 revenue above estimates as loss widens
Rocket Lab USA Inc (NASDAQ:RKLB) reported record second quarter revenue that exceeded Wall Street expectations, while its quarterly loss was wider than analysts had forecast, as the company continued to invest in its Neutron rocket and other growth initiatives. Revenue for the quarter ended June 30 reached $234 million, up 62% year over year and ahead of estimates of roughly $231.6 million to $232 million.
Rocket Lab's Record Quarter Still Left Investors Waiting on Neutron
Rocket Lab NASDAQ: RKLB reported its Q2 2026 results after the close on Monday, Aug. 11, and by almost every operational measure, it was the strongest quarter in the company's history. Record revenue, a record backlog, more than $1 billion in new contracts, and continued progress toward Neutron's debut.
